These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 33147555)
21. The Microbiome and Cancer: Creating Friendly Neighborhoods and Removing the Foes Within. Parida S; Sharma D Cancer Res; 2021 Feb; 81(4):790-800. PubMed ID: 33148661 [TBL] [Abstract][Full Text] [Related]
22. Microbiota: a key orchestrator of cancer therapy. Roy S; Trinchieri G Nat Rev Cancer; 2017 May; 17(5):271-285. PubMed ID: 28303904 [TBL] [Abstract][Full Text] [Related]
23. Microbiota-Derived Metabolites in Tumor Progression and Metastasis. Rossi T; Vergara D; Fanini F; Maffia M; Bravaccini S; Pirini F Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806665 [TBL] [Abstract][Full Text] [Related]
24. Cancer Microbiome; Opportunities and Challenges. Nallanchakravarthula S; Amruta N; Ramamurthy C Endocr Metab Immune Disord Drug Targets; 2021; 21(2):215-229. PubMed ID: 32819239 [TBL] [Abstract][Full Text] [Related]
25. Exosomes Function in Tumor Immune Microenvironment. Huang Y; Liu K; Li Q; Yao Y; Wang Y Adv Exp Med Biol; 2018; 1056():109-122. PubMed ID: 29754177 [TBL] [Abstract][Full Text] [Related]
26. Relevance of tumor microbiome in cancer incidence, prognosis, and its clinical implications in therapeutics. Bahuguna A; Dubey SK Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188956. PubMed ID: 37473857 [TBL] [Abstract][Full Text] [Related]
27. Gut microbiome and cancer immunotherapy. Li W; Deng Y; Chu Q; Zhang P Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593 [TBL] [Abstract][Full Text] [Related]
28. Mutagenesis by Microbe: the Role of the Microbiota in Shaping the Cancer Genome. Barrett M; Hand CK; Shanahan F; Murphy T; O'Toole PW Trends Cancer; 2020 Apr; 6(4):277-287. PubMed ID: 32209443 [TBL] [Abstract][Full Text] [Related]
29. The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy. Sommariva M; Le Noci V; Bianchi F; Camelliti S; Balsari A; Tagliabue E; Sfondrini L Cell Mol Life Sci; 2020 Jul; 77(14):2739-2749. PubMed ID: 31974656 [TBL] [Abstract][Full Text] [Related]
30. Microbiota as a mediator of cancer progression and therapy. Pope JL; Tomkovich S; Yang Y; Jobin C Transl Res; 2017 Jan; 179():139-154. PubMed ID: 27554797 [TBL] [Abstract][Full Text] [Related]
31. The Microbiome and Its Implications in Cancer Immunotherapy. Choudhry H Molecules; 2021 Jan; 26(1):. PubMed ID: 33401586 [TBL] [Abstract][Full Text] [Related]
32. Nanotechnology intervention of the microbiome for cancer therapy. Song W; Anselmo AC; Huang L Nat Nanotechnol; 2019 Dec; 14(12):1093-1103. PubMed ID: 31802032 [TBL] [Abstract][Full Text] [Related]
33. Intratumoral Microbiome: Foe or Friend in Reshaping the Tumor Microenvironment Landscape? Kyriazi AA; Karaglani M; Agelaki S; Baritaki S Cells; 2024 Jul; 13(15):. PubMed ID: 39120310 [TBL] [Abstract][Full Text] [Related]
34. Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota. Di Lorenzo A; Bolli E; Tarone L; Cavallo F; Conti L Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321934 [TBL] [Abstract][Full Text] [Related]
35. Relevance of harmful intratumoral microbiota in cancer progression and its clinical application. Yu R; Wang S; Han L Biomed Pharmacother; 2024 Sep; 178():117238. PubMed ID: 39106707 [TBL] [Abstract][Full Text] [Related]
36. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Iida N; Dzutsev A; Stewart CA; Smith L; Bouladoux N; Weingarten RA; Molina DA; Salcedo R; Back T; Cramer S; Dai RM; Kiu H; Cardone M; Naik S; Patri AK; Wang E; Marincola FM; Frank KM; Belkaid Y; Trinchieri G; Goldszmid RS Science; 2013 Nov; 342(6161):967-70. PubMed ID: 24264989 [TBL] [Abstract][Full Text] [Related]
37. The interplay between neutrophils and microbiota in cancer. Smith CK; Trinchieri G J Leukoc Biol; 2018 Oct; 104(4):701-715. PubMed ID: 30044897 [TBL] [Abstract][Full Text] [Related]
38. Leveraging the intratumoral microbiota to treat human cancer: are engineered exosomes an effective strategy? Qiu J; Jiang Y; Ye N; Jin G; Shi H; Qian D J Transl Med; 2024 Aug; 22(1):728. PubMed ID: 39103887 [TBL] [Abstract][Full Text] [Related]
39. Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy. Andrews MC; Reuben A; Gopalakrishnan V; Wargo JA Front Immunol; 2018; 9():946. PubMed ID: 29780391 [TBL] [Abstract][Full Text] [Related]
40. Mechanisms by Which the Intratumoral Microbiome May Potentiate Immunotherapy Response. Negrón-Figueroa D; Colbert LE J Clin Oncol; 2024 Oct; 42(28):3350-3352. PubMed ID: 39058969 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]